logo

LUPIN vs PGHL: Stock Comparison

LUPIN vs PROCTER & GAMBLE HEALTH LUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

LUPIN is the larger company by market capitalisation. LUPIN shows a lower P/E and faster revenue growth, while PROCTER & GAMBLE HEALTH L shows a higher ROE, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

LUPIN leads 4; PGHL leads 7 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

LUPINPGHL

Valuation lens

What price are you paying?

Market CapContext only
₹88,166 Cr
₹8,398 Cr
P/E RatioLUPIN has the lower reading
15.94x ✓
23.53x
P/B RatioLUPIN has the lower reading
3.93x ✓
16.01x
EPSPGHL has the higher reading
₹30.95
₹57.92 ✓
Book ValueContext only
₹492.38
₹316.01
Dividend YieldPGHL has the higher reading
0.92%
2.77% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
LUPIN is the larger company
₹88,166 Cr vs ₹8,398 Cr
P/E Ratio
LUPIN has a lower P/E
15.94x vs 23.53x
P/B Ratio
LUPIN has a lower P/B
3.93x vs 16.01x
EPS
PGHL has higher earnings per share
₹57.92 vs ₹30.95
Dividend Yield
PGHL has a higher dividend yield
2.77% vs 0.92%
Revenue Growth (TTM YoY)
LUPIN has faster revenue growth
31.9% vs 19.1%
EPS Growth (TTM YoY)
LUPIN has faster EPS growth
89% vs 54.6%
ROE
PGHL has a higher ROE
62.32% vs 23.79%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricLUPINPGHL
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricLUPINPGHL
Live Price₹1,922₹5,062.5
Day Change-2.14%0.29%
Volume7.29 L8,364
52-Week High₹2,529.5₹6,975
52-Week Low₹1,900₹4,707
Distance from 52W High-24.02%-27.42%

Valuation

MetricLUPINPGHL
Market Cap₹88,166 Cr₹8,398 Cr
P/E Ratio15.94x23.53x
P/B Ratio3.93x16.01x
EPS₹30.95₹57.92
Book Value₹492.38₹316.01
Dividend Yield0.92%2.77%

Growth

MetricLUPINPGHL
Revenue Growth (TTM YoY)31.9%19.1%
EPS Growth (TTM YoY)89%54.6%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricLUPINPGHL
ROE23.79%62.32%
ROCE22.95%92.1%
Net Margin17.65%23.22%
Operating Margin26.14%31.99%
Debt to Equity0.26x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricLUPINPGHL
Promoter Holding46.57%0%
FII Holding22.42%▲ 0.71 pp6.42%▲ 0.09 pp
DII Holding24.65%▼ 0.67 pp12.63%▲ 0.19 pp
Public Holding6.08%▼ 0.03 pp29.13%▼ 0.29 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: LUPIN and PROCTER & GAMBLE HEALTH L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.